tiprankstipranks
Trending News
More News >
SpectraCure AB (DE:2OK)
FRANKFURT:2OK
Germany Market

SpectraCure AB (2OK) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Sell
4Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Neutral
2Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
SpectraCure AB’s (2OK) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting SpectraCure AB is a Sell.
SpectraCure AB’s (2OK) 20-Day exponential moving average is 0.12, while SpectraCure AB’s (2OK) share price is €0.12, making it a Sell.
SpectraCure AB’s (2OK) 50-Day exponential moving average is 0.13, while SpectraCure AB’s (2OK) share price is €0.12, making it a Sell.

SpectraCure AB (2OK) Pivot Points

Apr 22, 2025, 06:01 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.12
0.12
0.12
0.12
0.12
0.12
0.12
Fibonacci
0.12
0.12
0.12
0.12
0.12
0.12
0.12
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

SpectraCure AB (2OK) Moving Averages

Apr 22, 2025, 06:01 PM
Period
Simple
Exponential
MA5
0.12Buy
0.12Sell
MA10
0.12Buy
0.12Sell
MA20
0.13Sell
0.12Sell
MA50
0.14Sell
0.13Sell
MA100
0.15Sell
0.14Sell
MA200
0.15Sell
0.15Sell
SpectraCure AB’s (2OK) 10-Day exponential moving average is 0.12, while SpectraCure AB’s (2OK) share price is €0.12, making it a Sell.
SpectraCure AB’s (2OK) 100-Day exponential moving average is 0.14, while SpectraCure AB’s (2OK) share price is €0.12, making it a Sell.
SpectraCure AB’s (2OK) stock price is €0.12 and SpectraCure AB’s (2OK) 50-day simple moving average is 0.14, creating a Sell signal.
SpectraCure AB’s (2OK) stock price is €0.12 and SpectraCure AB’s (2OK) 100-day simple moving average is 0.15, creating a Sell signal.
SpectraCure AB’s (2OK) stock price is €0.12 and SpectraCure AB’s (2OK) 200-day simple moving average is 0.15, creating a Sell signal.

SpectraCure AB (2OK) Technical Indicators

Apr 22, 2025, 06:01 PM
Name
Value
Implied Action
RSI (14)
47.47
Neutral
STOCH (9,6)
61.48
Neutral
STOCHRSI (14)
61.48
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
14.68
Buy
Williams %R
-53.33
Buy
CCI (14)
-67.42
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
57.14
Neutral
ROC
0.00
Sell
SpectraCure AB’s (2OK) Relative Strength Index (RSI) is 47.47, creating a Neutral signal.
SpectraCure AB’s (2OK) Trend Strength Indicator (ADX) is 14.68, creating a Buy signal.
SpectraCure AB’s (2OK) Commodity Channel Index (CCI) is -67.42, creating a Neutral signal.

FAQ

Is 2OK a Buy, Hold, or Sell?
Based on 2OK’s technical indicators, 2OK is a Sell.
    What is 2OK’s RSI (14)?
    2OK’s RSI (14) is 47.47, which suggests 2OK is a Neutral.
      What is 2OK’s MACD?
      2OK’s MACD is >-0.01, which suggests 2OK is a Sell.
        What is 2OK’s 5-day moving average?
        2OK’s 5-day moving average is 0.12, which suggests 2OK is a Buy.
          What is 2OK’s 20-day moving average?
          2OK 20-day moving average is 0.13, which suggests 2OK is a Sell.
            What is 2OK’s 50-day moving average?
            2OK’s 50-day moving average is 0.14, which suggests 2OK is a Sell.
              What is 2OK’s 200-day moving average?
              2OK’s 200-day moving average is 0.15, which suggests 2OK is a Sell.
                What is 2OK’s Williams % R (14)?
                2OK’s Williams % R (14) is -53.33, which suggests 2OK is a Buy.
                  What is 2OK’s CCI (14)?
                  2OK’s CCI (14) is -67.42, which suggests 2OK is a Neutral.
                    What is the share price of SpectraCure AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis